Published in J Clin Invest on January 01, 2003
Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity (2007) 1.06
Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus. J Exp Med (2005) 0.97
Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosus. PLoS One (2009) 0.93
Selective regulation of autoreactive B cells by FcgammaRIIB. J Autoimmun (2009) 0.93
Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum (2009) 0.90
Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies. Ann Oncol (2012) 0.86
Lessons from an anti-DNA autoantibody. Mol Immunol (2011) 0.85
Hormonal milieu at time of B cell activation controls duration of autoantibody response. J Autoimmun (2014) 0.84
Interferon regulatory factor 1 marks activated genes and can induce target gene expression in systemic lupus erythematosus. Arthritis Rheumatol (2015) 0.84
Increased levels of prolactin receptor expression correlate with the early onset of lupus symptoms and increased numbers of transitional-1 B cells after prolactin treatment. BMC Immunol (2012) 0.83
Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages. J Immunol (2012) 0.80
Pregnancy and the Immune System: General Overview and the Gastroenterological Perspective. Dig Dis Sci (2015) 0.80
Human prolactin promotes human secondary immunoglobulin response in human/SCID mouse chimeras. Clin Vaccine Immunol (2006) 0.78
The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. Rheumatology (Oxford) (2016) 0.78
Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice. Clin Exp Immunol (2013) 0.77
Diminished prolactin from chlordecone treatment in ovariectomized (NZBxNZW)F(1) mice. Int Immunopharmacol (2007) 0.76
Prolactin and Dehydroepiandrosterone Levels in Women with Systemic Lupus Erythematosus: The Role of the Extrapituitary Prolactin Promoter Polymorphism at -1149G/T. J Immunol Res (2015) 0.75
Prolactin: Friend or Foe in Central Nervous System Autoimmune Inflammation? Int J Mol Sci (2016) 0.75
Acute onset polymyositis after prolactinoma extirpation. Case Rep Rheumatol (2014) 0.75
Prolactinoma and systemic lupus erythematosus: do serum prolactin levels matter? Clin Rheumatol (2006) 0.75
Production of monoclonal antibodies: strategy and tactics. J Immunol Methods (1980) 9.28
Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol (2000) 4.57
Delineating the genetic basis of systemic lupus erythematosus. Immunity (2001) 4.02
Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat Immunol (2002) 3.75
A gender gap in autoimmunity. Science (1999) 3.33
Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol (1985) 3.31
The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol (2001) 2.87
Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med (2001) 2.57
Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus. Lupus (1998) 2.09
The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity (2001) 2.04
Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev (1996) 1.89
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest (1996) 1.86
Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol (2002) 1.77
Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest (2002) 1.76
Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol (2001) 1.75
Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A (1997) 1.61
Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci U S A (2000) 1.43
The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol (1999) 1.42
Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem Biophys Res Commun (1984) 1.33
Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol (2002) 1.31
Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol (1992) 1.27
Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J Immunol (1998) 1.25
Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol (1991) 1.23
Induction of tolerance to an IgG autoantibody. Proc Natl Acad Sci U S A (1992) 1.19
Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J (1989) 1.18
Lack of allelic exclusion permits autoreactive B cells to escape deletion. J Immunol (1994) 1.12
B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Int Immunol (1998) 1.07
Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci U S A (1986) 1.07
Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology (1990) 1.07
Estrogen, prolactin, and autoimmunity: actions and interactions. Int Immunopharmacol (2001) 1.06
Light chain usage in anti-double-stranded DNA B cell subsets: role in cell fate determination. J Exp Med (1997) 1.02
Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol (1993) 1.02
Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus (1998) 1.00
Characterization of anti-DNA B cells that escape negative selection. Eur J Immunol (1999) 1.00
Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol (1995) 0.99
Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest (2000) 0.96
Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci (1992) 0.95
Hyperprolactinemia in acute myeloid leukemia and indication of ectopic expression of human prolactin in blast cells of a patient of subtype M4. Leuk Res (1990) 0.95
Bcl-2 leads to expression of anti-DNA B cells but no nephritis: a model for a clinical subset. Eur J Immunol (1999) 0.92
Prolactin receptors on large granular lymphocytes: dual regulation by cyclosporin A. Brain Behav Immun (1988) 0.91
Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus (2001) 0.89
Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol (1996) 0.89
Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line. J Neuroimmunol (1997) 0.88
Pituitary hormones modulate cell-cell interactions between thymocytes and thymic epithelial cells. J Neuroimmunol (1997) 0.88
Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinology (1992) 0.87
Prolactin, a lymphocyte growth and survival factor. Lupus (2001) 0.87
Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann N Y Acad Sci (1998) 0.87
Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol (1994) 0.87
Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells. Int J Cancer (2000) 0.86
Polymorphisms of the human prolactin gene--implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus (2001) 0.86
Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus (1996) 0.86
Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus (1998) 0.86
A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J Clin Endocrinol Metab (1997) 0.85
Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology (1992) 0.85
Prolactin and systemic lupus erythematosus. Ann Med Interne (Paris) (1996) 0.84
Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus (1995) 0.84
Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol (1994) 0.83
Hyperprolactinemia in systemic lupus erythematosus? Scand J Rheumatol (1996) 0.83
Prolactin levels in men with SLE and RA. J Rheumatol (1990) 0.83
Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma. Clin Exp Rheumatol (1998) 0.81
Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion. Biomed Pharmacother (1997) 0.81
Prolactin and gonadal hormones: a key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus. Lupus (1993) 0.81
Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations. J Rheumatol (1996) 0.81
Sex hormones in chronic systemic lupus erythematosus. Correlation with clinical and biological parameters. Ann Med Interne (Paris) (1994) 0.80
Constitutive expression of bcl-2 in B cells causes a lethal form of lupuslike autoimmune disease after induction of neonatal tolerance to H-2b alloantigens. J Exp Med (1996) 0.79
T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment. Clin Immunol Immunopathol (1986) 0.79
Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice. Proc Natl Acad Sci U S A (1996) 0.78
Hyperprolactinemia. Evaluation and management. Endocrinol Metab Clin North Am (1992) 0.77
Landscape of transcription in human cells. Nature (2012) 20.18
Regulation of cellular metabolism by protein lysine acetylation. Science (2010) 10.55
Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med (2005) 5.50
Cognition and immunity; antibody impairs memory. Immunity (2004) 3.40
The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2006) 3.05
Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A (2006) 2.97
Long noncoding RNAs are rarely translated in two human cell lines. Genome Res (2012) 2.64
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A (2006) 2.51
On the track of neuropsychiatric lupus. Arthritis Rheum (2003) 2.39
Enhanced reversibility and unusual microstructure of a phase-transforming material. Nature (2013) 2.21
Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest (2006) 2.05
Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum (2008) 2.00
Female mouse fetal loss mediated by maternal autoantibody. J Exp Med (2012) 1.92
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum (2006) 1.87
Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med (2006) 1.81
Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol Cell Proteomics (2003) 1.77
Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest (2002) 1.76
Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Mol Biol Cell (2004) 1.73
XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development. J Exp Med (2009) 1.71
A model for harmonizing flow cytometry in clinical trials. Nat Immunol (2010) 1.70
Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity. Proc Natl Acad Sci U S A (2011) 1.66
Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci U S A (2010) 1.65
Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum (2010) 1.55
Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med (2008) 1.54
Amino acid residue specific stable isotope labeling for quantitative proteomics. Rapid Commun Mass Spectrom (2002) 1.54
Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus. J Immunol (2004) 1.53
Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity. Mol Pharmacol (2005) 1.47
Inhibition of histone deacetylases potentiates BMP9-induced osteogenic signaling in mouse mesenchymal stem cells. Cell Physiol Biochem (2013) 1.47
Modifications of superoxide dismutase (SOD1) in human erythrocytes: a possible role in amyotrophic lateral sclerosis. J Biol Chem (2009) 1.46
B cell selection and susceptibility to autoimmunity. J Immunol (2005) 1.46
Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One (2008) 1.45
The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity (2012) 1.44
Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain (2008) 1.42
Inactivation of a bacterial virulence pheromone by phagocyte-derived oxidants: new role for the NADPH oxidase in host defense. Proc Natl Acad Sci U S A (2004) 1.42
The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One (2010) 1.42
Jmjd1a demethylase-regulated histone modification is essential for cAMP-response element modulator-regulated gene expression and spermatogenesis. J Biol Chem (2009) 1.38
Whole human genome proteogenomic mapping for ENCODE cell line data: identifying protein-coding regions. BMC Genomics (2013) 1.38
Identification of an antigen-specific B cell population. J Immunol Methods (2003) 1.36
HMGB1 mediates cognitive impairment in sepsis survivors. Mol Med (2012) 1.33
Effects of prayer and religious expression within computer support groups on women with breast cancer. Psychooncology (2007) 1.31
Accusations of murder and euthanasia in end-of-life care. J Palliat Med (2005) 1.28
Structural characterization of formaldehyde-induced cross-links between amino acids and deoxynucleosides and their oligomers. J Am Chem Soc (2010) 1.28
Tolerogenic function of Blimp-1 in dendritic cells. J Exp Med (2011) 1.26
ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells. Eur J Immunol (2007) 1.25
Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions. Arthritis Rheum (2012) 1.23
Pentamidine reduces hERG expression to prolong the QT interval. Br J Pharmacol (2005) 1.23
PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. Cancer Res (2005) 1.23
Steroid receptor coactivator 3 maintains circulating insulin-like growth factor I (IGF-I) by controlling IGF-binding protein 3 expression. Mol Cell Biol (2008) 1.17
CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet (2012) 1.16
Requirement for cyclin D3 in germinal center formation and function. Cell Res (2010) 1.16
HDA18 affects cell fate in Arabidopsis root epidermis via histone acetylation at four kinase genes. Plant Cell (2013) 1.16
Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J Autoimmun (2009) 1.15
Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood (2004) 1.13
Current and novel therapeutics in the treatment of systemic lupus erythematosus. J Allergy Clin Immunol (2011) 1.13
Hormonal modulation of B cell development and repertoire selection. Mol Immunol (2005) 1.12
Flightless I homolog negatively modulates the TLR pathway. J Immunol (2006) 1.11
A new and facile synthesis of quinazoline-2,4(1H,3H)-diones. Org Lett (2009) 1.10
Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration. Cancer Res (2011) 1.08
Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis. Arthritis Care Res (Hoboken) (2011) 1.08
Receptor editing in peripheral B cell tolerance. Proc Natl Acad Sci U S A (2005) 1.08
Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice. J Immunol (2005) 1.08
Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins. J Immunol (2009) 1.06
The dynamic alterations of H2AX complex during DNA repair detected by a proteomic approach reveal the critical roles of Ca(2+)/calmodulin in the ionizing radiation-induced cell cycle arrest. Mol Cell Proteomics (2006) 1.06
Synthesis of metal-selenide nanocrystals using selenium dioxide as the selenium precursor. Angew Chem Int Ed Engl (2008) 1.06
In vivo dual-tagging proteomic approach in studying signaling pathways in immune response. J Proteome Res (2005) 1.04
B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice. J Clin Invest (2008) 1.01
Improvement of image quality and radiation dose of CT perfusion of the brain by means of low-tube voltage (70 KV). Eur Radiol (2014) 1.00
Crosstalk between Wnt/β-catenin and estrogen receptor signaling synergistically promotes osteogenic differentiation of mesenchymal progenitor cells. PLoS One (2013) 1.00
Identification of DNA-reactive B cells in patients with systemic lupus erythematosus. J Immunol Methods (2008) 1.00
C1q limits dendritic cell differentiation and activation by engaging LAIR-1. Proc Natl Acad Sci U S A (2012) 0.99
Prolactin as a modulator of B cell function: implications for SLE. Biomed Pharmacother (2004) 0.99
S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway. PLoS One (2013) 0.99
Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. J Immunol (2006) 0.98
Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells. J Orthop Res (2013) 0.98
Global investigation of p53-induced apoptosis through quantitative proteomic profiling using comparative amino acid-coded tagging. Mol Cell Proteomics (2004) 0.98
The role of B cells in lupus pathogenesis. Int J Biochem Cell Biol (2009) 0.97
Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus. J Exp Med (2005) 0.97
The autoimmunity-associated BLK haplotype exhibits cis-regulatory effects on mRNA and protein expression that are prominently observed in B cells early in development. Hum Mol Genet (2012) 0.97
Differential roles of estrogen receptors α and β in control of B-cell maturation and selection. Mol Med (2010) 0.97
Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus. Arthritis Rheum (2006) 0.96
SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heart. PLoS One (2012) 0.96
Upconverting near-infrared light through energy management in core-shell-shell nanoparticles. Angew Chem Int Ed Engl (2013) 0.96
Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. Cell Metab (2012) 0.95
Bone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla. Stem Cells Dev (2014) 0.95
Enhanced selection of high affinity DNA-reactive B cells following cyclophosphamide treatment in mice. PLoS One (2010) 0.94
Decade of molecular targeted therapy: abdominal manifestations of drug toxicities--what radiologists should know. AJR Am J Roentgenol (2012) 0.94
Residue-specific mass signatures for the efficient detection of protein modifications by mass spectrometry. Anal Chem (2002) 0.94
Identification of lysine 37 of histone H2B as a novel site of methylation. PLoS One (2011) 0.94
Pulse steroids: how much is enough? Autoimmun Rev (2005) 0.94
Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice. Exp Gerontol (2008) 0.93
Unambiguous characterization of site-specific phosphorylation of leucine-rich repeat Fli-I-interacting protein 2 (LRRFIP2) in Toll-like receptor 4 (TLR4)-mediated signaling. J Biol Chem (2011) 0.93
Selective regulation of autoreactive B cells by FcgammaRIIB. J Autoimmun (2009) 0.93
Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosus. PLoS One (2009) 0.93
Tamoxifen blocks estrogen-induced B cell maturation but not survival. J Immunol (2005) 0.93
Use of deuterium-labeled lysine for efficient protein identification and peptide de novo sequencing. Anal Chem (2002) 0.92
Precise peptide sequencing and protein quantification in the human proteome through in vivo lysine-specific mass tagging. J Am Soc Mass Spectrom (2003) 0.92
Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells. Mol Med (2008) 0.92